nodes	percent_of_prediction	percent_of_DWPC	metapath
Atropine—Granisetron—CYP1A1—polycystic ovary syndrome	0.00531	1	CrCbGaD
Atropine—Heartburn—Metformin—polycystic ovary syndrome	0.0014	0.0835	CcSEcCtD
Atropine—Blood disorder—Metformin—polycystic ovary syndrome	0.00115	0.0688	CcSEcCtD
Atropine—Nasal congestion—Metformin—polycystic ovary syndrome	0.000766	0.0458	CcSEcCtD
Atropine—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.000715	0.0428	CcSEcCtD
Atropine—Lethargy—Metformin—polycystic ovary syndrome	0.000712	0.0426	CcSEcCtD
Atropine—Dehydration—Metformin—polycystic ovary syndrome	0.000649	0.0388	CcSEcCtD
Atropine—Abdominal distension—Metformin—polycystic ovary syndrome	0.000607	0.0363	CcSEcCtD
Atropine—Angina pectoris—Metformin—polycystic ovary syndrome	0.000587	0.0351	CcSEcCtD
Atropine—Drowsiness—Metformin—polycystic ovary syndrome	0.000537	0.0322	CcSEcCtD
Atropine—Bradycardia—Metformin—polycystic ovary syndrome	0.000491	0.0294	CcSEcCtD
Atropine—Flushing—Metformin—polycystic ovary syndrome	0.000448	0.0268	CcSEcCtD
Atropine—Erythema—Metformin—polycystic ovary syndrome	0.00042	0.0251	CcSEcCtD
Atropine—Dysgeusia—Metformin—polycystic ovary syndrome	0.000411	0.0246	CcSEcCtD
Atropine—Vision blurred—Metformin—polycystic ovary syndrome	0.000396	0.0237	CcSEcCtD
Atropine—Syncope—Metformin—polycystic ovary syndrome	0.000377	0.0225	CcSEcCtD
Atropine—Palpitations—Metformin—polycystic ovary syndrome	0.000371	0.0222	CcSEcCtD
Atropine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000369	0.0221	CcSEcCtD
Atropine—Chest pain—Metformin—polycystic ovary syndrome	0.000358	0.0214	CcSEcCtD
Atropine—Oedema—Metformin—polycystic ovary syndrome	0.000343	0.0205	CcSEcCtD
Atropine—Shock—Metformin—polycystic ovary syndrome	0.000337	0.0202	CcSEcCtD
Atropine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000331	0.0198	CcSEcCtD
Atropine—Hypotension—Metformin—polycystic ovary syndrome	0.00032	0.0192	CcSEcCtD
Atropine—Dyspnoea—Metformin—polycystic ovary syndrome	0.000306	0.0183	CcSEcCtD
Atropine—Somnolence—Metformin—polycystic ovary syndrome	0.000305	0.0182	CcSEcCtD
Atropine—Dyspepsia—Metformin—polycystic ovary syndrome	0.000302	0.0181	CcSEcCtD
Atropine—Fatigue—Metformin—polycystic ovary syndrome	0.000296	0.0177	CcSEcCtD
Atropine—Constipation—Metformin—polycystic ovary syndrome	0.000293	0.0175	CcSEcCtD
Atropine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000282	0.0169	CcSEcCtD
Atropine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00028	0.0168	CcSEcCtD
Atropine—Urticaria—Metformin—polycystic ovary syndrome	0.000272	0.0163	CcSEcCtD
Atropine—Abdominal pain—Metformin—polycystic ovary syndrome	0.000271	0.0162	CcSEcCtD
Atropine—Asthenia—Metformin—polycystic ovary syndrome	0.000246	0.0147	CcSEcCtD
Atropine—Pruritus—Metformin—polycystic ovary syndrome	0.000243	0.0145	CcSEcCtD
Atropine—Diarrhoea—Metformin—polycystic ovary syndrome	0.000235	0.014	CcSEcCtD
Atropine—CHRM5—Signaling Pathways—INSR—polycystic ovary syndrome	0.000228	0.000233	CbGpPWpGaD
Atropine—Dizziness—Metformin—polycystic ovary syndrome	0.000227	0.0136	CcSEcCtD
Atropine—CHRM4—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000226	0.000231	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000226	0.000231	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000225	0.00023	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000223	0.000228	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000222	0.000227	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PGR—polycystic ovary syndrome	0.00022	0.000225	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00022	0.000225	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000219	0.000224	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000219	0.000224	CbGpPWpGaD
Atropine—Vomiting—Metformin—polycystic ovary syndrome	0.000218	0.013	CcSEcCtD
Atropine—CHRM3—Metabolism—SULT2A1—polycystic ovary syndrome	0.000217	0.000222	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000217	0.000222	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000216	0.000221	CbGpPWpGaD
Atropine—Rash—Metformin—polycystic ovary syndrome	0.000216	0.0129	CcSEcCtD
Atropine—Dermatitis—Metformin—polycystic ovary syndrome	0.000216	0.0129	CcSEcCtD
Atropine—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000215	0.00022	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000215	0.00022	CbGpPWpGaD
Atropine—Headache—Metformin—polycystic ovary syndrome	0.000215	0.0128	CcSEcCtD
Atropine—CHRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000214	0.000219	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—FST—polycystic ovary syndrome	0.000213	0.000218	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000213	0.000218	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000213	0.000218	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000212	0.000217	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000212	0.000216	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	0.000211	0.000216	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000211	0.000216	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PGR—polycystic ovary syndrome	0.000211	0.000216	CbGpPWpGaD
Atropine—CHRM3—Metabolism—RRM2—polycystic ovary syndrome	0.00021	0.000215	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00021	0.000215	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000209	0.000214	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000209	0.000214	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—LHB—polycystic ovary syndrome	0.000208	0.000213	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000207	0.000211	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000206	0.000211	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000205	0.000209	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000205	0.000209	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000204	0.000209	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000204	0.000208	CbGpPWpGaD
Atropine—Nausea—Metformin—polycystic ovary syndrome	0.000204	0.0122	CcSEcCtD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000203	0.000208	CbGpPWpGaD
Atropine—CHRM3—Metabolism—YAP1—polycystic ovary syndrome	0.000203	0.000207	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000202	0.000206	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000198	0.000202	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000197	0.000202	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000197	0.000202	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000197	0.000202	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000197	0.000201	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000196	0.0002	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000196	0.0002	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000196	0.0002	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000195	0.0002	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000195	0.0002	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—SCT—polycystic ovary syndrome	0.000195	0.0002	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000195	0.000199	CbGpPWpGaD
Atropine—CHRM3—Metabolism—NAMPT—polycystic ovary syndrome	0.000195	0.000199	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000193	0.000198	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000193	0.000198	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000193	0.000197	CbGpPWpGaD
Atropine—CHRM3—Metabolism—CYP11A1—polycystic ovary syndrome	0.000192	0.000197	CbGpPWpGaD
Atropine—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000191	0.000196	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000191	0.000195	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00019	0.000195	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.00019	0.000194	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000189	0.000193	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000187	0.000191	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000187	0.000191	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000186	0.00019	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000184	0.000189	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000184	0.000188	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000183	0.000187	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000182	0.000186	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000182	0.000186	CbGpPWpGaD
Atropine—CHRM3—Metabolism—AKR1C3—polycystic ovary syndrome	0.000182	0.000186	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000181	0.000186	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000181	0.000186	CbGpPWpGaD
Atropine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000181	0.000185	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000181	0.000185	CbGpPWpGaD
Atropine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000181	0.000185	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00018	0.000184	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.00018	0.000184	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00018	0.000184	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000179	0.000183	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000179	0.000183	CbGpPWpGaD
Atropine—CHRM3—Metabolism—CYP17A1—polycystic ovary syndrome	0.000179	0.000183	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000179	0.000183	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PRL—polycystic ovary syndrome	0.000179	0.000183	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000177	0.000181	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000173	0.000176	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000172	0.000176	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000171	0.000175	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PRL—polycystic ovary syndrome	0.000171	0.000175	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000171	0.000174	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00017	0.000174	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000169	0.000173	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000169	0.000173	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000168	0.000172	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000168	0.000171	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000167	0.000171	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000165	0.000169	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000165	0.000169	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	0.000163	0.000166	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000162	0.000166	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000161	0.000165	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.00016	0.000164	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—INSR—polycystic ovary syndrome	0.00016	0.000163	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000158	0.000162	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000157	0.000161	CbGpPWpGaD
Atropine—CHRM3—Metabolism—TH—polycystic ovary syndrome	0.000155	0.000158	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000152	0.000156	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000152	0.000155	CbGpPWpGaD
Atropine—CHRM3—Metabolism—SLC2A4—polycystic ovary syndrome	0.00015	0.000154	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—GNAS—polycystic ovary syndrome	0.00015	0.000154	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00015	0.000154	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00015	0.000153	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.00015	0.000153	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000149	0.000153	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000148	0.000152	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000148	0.000151	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000148	0.000151	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000147	0.00015	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000147	0.00015	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	0.000145	0.000148	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000143	0.000147	CbGpPWpGaD
Atropine—CHRM3—Metabolism—CYP19A1—polycystic ovary syndrome	0.000141	0.000145	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000141	0.000144	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000138	0.000142	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000138	0.000141	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000138	0.000141	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000138	0.000141	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000138	0.000141	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000137	0.00014	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000136	0.000139	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000136	0.000139	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000133	0.000136	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000133	0.000135	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000132	0.000135	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000131	0.000134	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000131	0.000134	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00013	0.000133	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00013	0.000133	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000128	0.000131	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000128	0.000131	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000128	0.000131	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000127	0.00013	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000127	0.00013	CbGpPWpGaD
Atropine—CHRM3—Metabolism—GNAS—polycystic ovary syndrome	0.000126	0.000129	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	0.000126	0.000129	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000126	0.000129	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000126	0.000129	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000123	0.000126	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—LEP—polycystic ovary syndrome	0.000123	0.000126	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000121	0.000124	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000121	0.000124	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000121	0.000123	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IRS2—polycystic ovary syndrome	0.00012	0.000123	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.00012	0.000123	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—POMC—polycystic ovary syndrome	0.00012	0.000123	CbGpPWpGaD
Atropine—CHRM3—Metabolism—NCOR1—polycystic ovary syndrome	0.00012	0.000123	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PRL—polycystic ovary syndrome	0.00012	0.000123	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00012	0.000123	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000119	0.000122	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000119	0.000122	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000119	0.000122	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—LEP—polycystic ovary syndrome	0.000118	0.000121	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000116	0.000119	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000116	0.000118	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000115	0.000117	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000114	0.000117	CbGpPWpGaD
Atropine—CHRM3—Metabolism—CYP1A1—polycystic ovary syndrome	0.000114	0.000117	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000114	0.000116	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000113	0.000115	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	0.00011	0.000112	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IRS1—polycystic ovary syndrome	0.00011	0.000112	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	0.000106	0.000109	CbGpPWpGaD
Atropine—CHRM3—Metabolism—MTHFR—polycystic ovary syndrome	0.000106	0.000109	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000106	0.000108	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—POMC—polycystic ovary syndrome	0.000106	0.000108	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000106	0.000108	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—INS—polycystic ovary syndrome	0.000105	0.000108	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000105	0.000108	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000105	0.000107	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	0.000103	0.000105	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000102	0.000104	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000102	0.000104	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—POMC—polycystic ovary syndrome	0.000101	0.000104	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000101	0.000103	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—INS—polycystic ovary syndrome	0.000101	0.000103	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000101	0.000103	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.96e-05	0.000102	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	9.9e-05	0.000101	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NRG1—polycystic ovary syndrome	9.87e-05	0.000101	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	9.86e-05	0.000101	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	9.8e-05	0.0001	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	9.78e-05	0.0001	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IGF1—polycystic ovary syndrome	9.74e-05	9.96e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	9.74e-05	9.96e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—AKT2—polycystic ovary syndrome	9.74e-05	9.95e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	9.67e-05	9.89e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.66e-05	9.88e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.25e-05	9.46e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	9.2e-05	9.4e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	9.05e-05	9.26e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	8.62e-05	8.81e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—POMC—polycystic ovary syndrome	8.5e-05	8.69e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	8.48e-05	8.67e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	8.46e-05	8.65e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—INS—polycystic ovary syndrome	8.45e-05	8.64e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	8.37e-05	8.56e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	8.3e-05	8.49e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	8.27e-05	8.46e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	8.19e-05	8.38e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—TH—polycystic ovary syndrome	7.83e-05	8.01e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—IL6—polycystic ovary syndrome	7.78e-05	7.95e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	7.62e-05	7.79e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—IL6—polycystic ovary syndrome	7.45e-05	7.62e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	7.41e-05	7.57e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	7.38e-05	7.55e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	7.31e-05	7.47e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	7.17e-05	7.33e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	7.13e-05	7.29e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	7.11e-05	7.27e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	7.09e-05	7.25e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	7.07e-05	7.23e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	7.04e-05	7.2e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	7e-05	7.16e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	6.86e-05	7.01e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	6.85e-05	7.01e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	6.84e-05	6.99e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	6.83e-05	6.99e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	6.77e-05	6.92e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	6.77e-05	6.92e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.64e-05	6.79e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.51e-05	6.66e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.49e-05	6.64e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.43e-05	6.58e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	6.4e-05	6.54e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.36e-05	6.51e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	6.09e-05	6.23e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	5.78e-05	5.91e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	5.38e-05	5.51e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	5.25e-05	5.36e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	5.23e-05	5.35e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	5.18e-05	5.29e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IL6—polycystic ovary syndrome	4.6e-05	4.7e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.48e-05	4.58e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.47e-05	4.57e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.42e-05	4.52e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IL6—polycystic ovary syndrome	4.4e-05	4.5e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	4.37e-05	4.46e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	4.31e-05	4.4e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—INS—polycystic ovary syndrome	4.28e-05	4.38e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	3.1e-05	3.17e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	3.09e-05	3.16e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	3.06e-05	3.13e-05	CbGpPWpGaD
